• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

刺突糖蛋白介导的 SARS 冠状病毒进入。

Spike Glycoprotein-Mediated Entry of SARS Coronaviruses.

机构信息

Center for Infectious Disease Research, Beijing Frontier Research Center for Biological Structure & Beijing Advanced Innovation Center for Structural Biology, Department of Basic Medical Sciences, School of Medicine, Tsinghua University, Beijing 100084, China.

出版信息

Viruses. 2020 Nov 11;12(11):1289. doi: 10.3390/v12111289.

DOI:10.3390/v12111289
PMID:33187074
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7696831/
Abstract

Severe acute respiratory syndrome coronavirus (SARS-CoV) and SARS-CoV-2 are enveloped, positive-sense, single-stranded RNA viruses and causes of epidemic diseases that have resulted in public health emergencies worldwide. Angiotensin-converting enzyme 2 (ACE2) is the receptor that allows the entry of these two viruses into host cells, a key step in the life cycle of the pathogens. The characterization of the interactions of ACE2 with the viral spike glycoproteins and structural studies of the ACE2-binding-induced conformational changes in the viral spike glycoproteins have furthered our understanding of the entry processes of these two viruses, and these studies provide useful information that will facilitate the development of antiviral agents and vaccines to control the diseases.

摘要

严重急性呼吸综合征冠状病毒(SARS-CoV)和 SARS-CoV-2 是包膜、正链、单链 RNA 病毒,可引起全球性传染病疫情,已构成公共卫生紧急事件。血管紧张素转换酶 2(ACE2)是这两种病毒进入宿主细胞的受体,是病原体生命周期中的关键步骤。对 ACE2 与病毒刺突糖蛋白相互作用的特性以及 ACE2 结合诱导的病毒刺突糖蛋白构象变化的结构研究,进一步加深了我们对这两种病毒进入过程的理解,这些研究提供了有用的信息,有助于开发抗病毒药物和疫苗来控制这些疾病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba34/7696831/5583042b7655/viruses-12-01289-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba34/7696831/f763384fef35/viruses-12-01289-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba34/7696831/5583042b7655/viruses-12-01289-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba34/7696831/f763384fef35/viruses-12-01289-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba34/7696831/5583042b7655/viruses-12-01289-g002.jpg

相似文献

1
Spike Glycoprotein-Mediated Entry of SARS Coronaviruses.刺突糖蛋白介导的 SARS 冠状病毒进入。
Viruses. 2020 Nov 11;12(11):1289. doi: 10.3390/v12111289.
2
Receptor utilization of angiotensin-converting enzyme 2 (ACE2) indicates a narrower host range of SARS-CoV-2 than that of SARS-CoV.血管紧张素转化酶 2(ACE2)的受体利用表明,SARS-CoV-2 的宿主范围比 SARS-CoV 更窄。
Transbound Emerg Dis. 2021 May;68(3):1046-1053. doi: 10.1111/tbed.13792. Epub 2020 Sep 5.
3
, and Models for Monitoring SARS-CoV-2 Spike/Human ACE2 Complex, Viral Entry and Cell Fusion.用于监测 SARS-CoV-2 刺突/人 ACE2 复合物、病毒进入和细胞融合的模型。
Viruses. 2021 Feb 25;13(3):365. doi: 10.3390/v13030365.
4
Spike glycoproteins: Their significance for corona viruses and receptor binding activities for pathogenesis and viral survival.刺突糖蛋白:它们在冠状病毒中的意义及对发病机制和病毒存活的受体结合活性。
Microb Pathog. 2021 Jan;150:104719. doi: 10.1016/j.micpath.2020.104719. Epub 2020 Dec 26.
5
Interaction of Human ACE2 to Membrane-Bound SARS-CoV-1 and SARS-CoV-2 S Glycoproteins.人血管紧张素转换酶 2 与 SARS-CoV-1 和 SARS-CoV-2 表面糖蛋白的相互作用。
Viruses. 2020 Sep 29;12(10):1104. doi: 10.3390/v12101104.
6
Why are ACE2 binding coronavirus strains SARS-CoV/SARS-CoV-2 wild and NL63 mild?为何 ACE2 结合冠状病毒株 SARS-CoV/SARS-CoV-2 为野生型,NL63 为温和型?
Proteins. 2021 Apr;89(4):389-398. doi: 10.1002/prot.26024. Epub 2020 Nov 27.
7
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)进入细胞依赖于 ACE2 和 TMPRSS2,可被一种临床验证的蛋白酶抑制剂所阻断。
Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.
8
The SARS-CoV-2 Spike Glycoprotein as a Drug and Vaccine Target: Structural Insights into Its Complexes with ACE2 and Antibodies.SARS-CoV-2 刺突糖蛋白作为药物和疫苗靶点:与 ACE2 和抗体复合物的结构见解。
Cells. 2020 Oct 22;9(11):2343. doi: 10.3390/cells9112343.
9
Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein.SARS-COV-2 刺突糖蛋白的优化假型条件。
J Virol. 2020 Oct 14;94(21). doi: 10.1128/JVI.01062-20.
10
Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19.血管紧张素转换酶 2(ACE2)在 COVID-19 所致急性呼吸窘迫综合征发病机制中的作用。
Front Immunol. 2021 Dec 22;12:732690. doi: 10.3389/fimmu.2021.732690. eCollection 2021.

引用本文的文献

1
Replication Features of SARS-CoV-2 and Advantages of Targeting S Protein with Aptamers to Block Viral Entry.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的复制特征以及适配体靶向刺突蛋白(S蛋白)以阻断病毒进入的优势
ACS Omega. 2025 Apr 21;10(16):15840-15851. doi: 10.1021/acsomega.4c10933. eCollection 2025 Apr 29.
2
Discovering natural products as potential inhibitors of SARS-CoV-2 spike proteins.发现天然产物作为严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白的潜在抑制剂。
Sci Rep. 2025 Jan 2;15(1):200. doi: 10.1038/s41598-024-83637-4.
3
Design, Synthesis and Biological Exploration of Novel -(9-Ethyl-9-Carbazol-3-yl)Acetamide-Linked Benzofuran-1,2,4-Triazoles as Anti-SARS-CoV-2 Agents: Combined Wet/Dry Approach Targeting Main Protease (M), Spike Glycoprotein and RdRp.

本文引用的文献

1
Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis.去除furin 酶切位点可减轻 SARS-CoV-2 的发病机制。
Nature. 2021 Mar;591(7849):293-299. doi: 10.1038/s41586-021-03237-4. Epub 2021 Jan 25.
2
Heparin Inhibits Cellular Invasion by SARS-CoV-2: Structural Dependence of the Interaction of the Spike S1 Receptor-Binding Domain with Heparin.肝素抑制 SARS-CoV-2 的细胞侵袭:刺突 S1 受体结合域与肝素相互作用的结构依赖性。
Thromb Haemost. 2020 Dec;120(12):1700-1715. doi: 10.1055/s-0040-1721319. Epub 2020 Dec 23.
3
Spike mutation D614G alters SARS-CoV-2 fitness.
新型-(9-乙基-9-咔唑-3-基)乙酰胺连接的苯并呋喃-1,2,4-三唑作为抗SARS-CoV-2药物的设计、合成及生物学研究:针对主要蛋白酶(M)、刺突糖蛋白和RNA依赖的RNA聚合酶的湿/干联合方法
Int J Mol Sci. 2024 Nov 26;25(23):12708. doi: 10.3390/ijms252312708.
4
Research progress of spike protein mutation of SARS-CoV-2 mutant strain and antibody development.新型冠状病毒变异株刺突蛋白突变及抗体研发的研究进展
Front Immunol. 2024 Nov 18;15:1407149. doi: 10.3389/fimmu.2024.1407149. eCollection 2024.
5
Revolutionizing Gastrointestinal Disorder Management: Cutting-Edge Advances and Future Prospects.革新胃肠道疾病管理:前沿进展与未来前景
J Clin Med. 2024 Jul 8;13(13):3977. doi: 10.3390/jcm13133977.
6
Cyanobacteria Lectin (MVL) Interacts with SARS-CoV-2 Spike Protein Receptor Binding Domains (RBDs) via Protein-Protein Interaction.蓝藻凝集素 (MVL) 通过蛋白-蛋白相互作用与 SARS-CoV-2 刺突蛋白受体结合域 (RBD) 相互作用。
Int J Mol Sci. 2024 Jun 18;25(12):6696. doi: 10.3390/ijms25126696.
7
Guillain-Barre syndrome: An autoimmune disorder post-COVID-19 vaccination?格林-巴利综合征:新冠病毒疫苗接种后的一种自身免疫性疾病?
Clin Immunol Commun. 2022 Dec;2:1-5. doi: 10.1016/j.clicom.2021.12.002. Epub 2021 Dec 23.
8
Detection of Coronavirus Disease 2019 (COVID-19) by TaqMan Real-Time PCR in Iran.伊朗采用TaqMan实时荧光定量PCR法检测2019冠状病毒病(COVID-19)
Maedica (Bucur). 2023 Sep;18(3):442-446. doi: 10.26574/maedica.2023.18.3.442.
9
Nano-biosensor for SARS-CoV-2/COVID-19 detection: methods, mechanism and interface design.用于检测新型冠状病毒/新冠肺炎的纳米生物传感器:方法、机制及界面设计
RSC Adv. 2023 Jun 13;13(26):17883-17906. doi: 10.1039/d3ra02560h. eCollection 2023 Jun 9.
10
Antiviral Potential of Small Molecules Cordycepin, Thymoquinone, and N6, N6-Dimethyladenosine Targeting SARS-CoV-2 Entry Protein ADAM17.小分子虫草素、百里醌和 N6,N6-二甲基腺苷针对 SARS-CoV-2 进入蛋白 ADAM17 的抗病毒潜力。
Molecules. 2022 Dec 19;27(24):9044. doi: 10.3390/molecules27249044.
刺突突变 D614G 改变了 SARS-CoV-2 的适应性。
Nature. 2021 Apr;592(7852):116-121. doi: 10.1038/s41586-020-2895-3. Epub 2020 Oct 26.
4
Neuropilin-1 is a host factor for SARS-CoV-2 infection.神经纤毛蛋白 1 是 SARS-CoV-2 感染的宿主因子。
Science. 2020 Nov 13;370(6518):861-865. doi: 10.1126/science.abd3072. Epub 2020 Oct 20.
5
Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity.神经纤毛蛋白-1 促进 SARS-CoV-2 细胞进入和感染性。
Science. 2020 Nov 13;370(6518):856-860. doi: 10.1126/science.abd2985. Epub 2020 Oct 20.
6
Neuropilin‑1 as a new potential SARS‑CoV‑2 infection mediator implicated in the neurologic features and central nervous system involvement of COVID‑19.神经纤毛蛋白 1 作为新型潜在的 SARS-CoV-2 感染介质,与 COVID-19 的神经特征和中枢神经系统受累相关。
Mol Med Rep. 2020 Nov;22(5):4221-4226. doi: 10.3892/mmr.2020.11510. Epub 2020 Sep 15.
7
Papain-Like Proteases as Coronaviral Drug Targets: Current Inhibitors, Opportunities, and Limitations.木瓜蛋白酶样蛋白酶作为冠状病毒药物靶点:当前的抑制剂、机遇与局限
Pharmaceuticals (Basel). 2020 Sep 28;13(10):277. doi: 10.3390/ph13100277.
8
Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant.结构与功能分析:D614G 型 SARS-CoV-2 刺突蛋白变异株。
Cell. 2020 Oct 29;183(3):739-751.e8. doi: 10.1016/j.cell.2020.09.032. Epub 2020 Sep 15.
9
Molecular Architecture of the SARS-CoV-2 Virus.SARS-CoV-2 病毒的分子结构。
Cell. 2020 Oct 29;183(3):730-738.e13. doi: 10.1016/j.cell.2020.09.018. Epub 2020 Sep 6.
10
Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2.针对 SARS-CoV 和 SARS-CoV-2 的受体结合域特异性人源中和单克隆抗体。
Signal Transduct Target Ther. 2020 Sep 22;5(1):212. doi: 10.1038/s41392-020-00318-0.